Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Advances in Therapy|December 21, 2018
Healthcare Costs of Smokers Using Varenicline Versus Nicotine-Replacement Therapy Patch in the United States: Evidence from Real-World PracticeLauren J Lee, Qian Li, Marianna Bruno, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 13, 2023
Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United StatesRahul Bhambri, A Carmine Colavecchia, Marianna Bruno, et al.Journal of Cardiac Failure|December 8, 2023
EstimATTR: A Simplified, Machine-Learning-Based Tool to Predict the Risk of Wild-Type Transthyretin Amyloid CardiomyopathyAdam Castaño, Stephen B Heitner, Ahmad Masri, et al.Future Cardiology|January 31, 2022
Applying diagnosis support systems in electronic health records to identify wild-type transthyretin amyloid cardiomyopathy riskConnor Willis, Alexandre H Watanabe, Justin Hughes, et al.Gene|November 6, 2012
Characterization of the first adult de novo case of 46,X,der(Y)t(X;Y)(p22.3;q11.2)Nenad Bukvic, Carla Cesarano, Caterina Ceccarini, et al.Nature Communications|May 12, 2021
A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathyAhsan Huda, Adam Castaño, Anindita Niyogi, et al.Drug Design, Development and Therapy|March 29, 2021
Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis StoryArianna Burton, Adam Castaño, Marianna Bruno, et al.American Heart Journal|July 3, 2023
Transthyretin amyloid cardiomyopathy among patients hospitalized for heart failure and performance of an adapted wild-type ATTR-CM machine learning model: Findings from GWTG-HFAnthony E Peters, Nicole Solomon, Karen Chiswell, et al.Pageof 2